"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
| Descriptor ID |
D006490
|
| MeSH Number(s) |
D27.505.954.502.270.463
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in this website by year, and whether "Hemostatics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 0 | 2 |
| 1998 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 3 | 5 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 5 | 0 | 5 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Analysis of Reported Adverse Events Related to Hemospray: An FDA MAUDE Database Study. J Clin Gastroenterol. 2024 Apr 01; 58(4):402-406.
-
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient. Anesthesiology. 2023 05 01; 138(5):535-560.
-
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation. Thromb Res. 2023 01; 221:97-104.
-
Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial. Br J Anaesth. 2023 02; 130(2):175-182.
-
Pediatric traumatic hemorrhagic shock consensus conference recommendations. J Trauma Acute Care Surg. 2023 01 01; 94(1S Suppl 1):S2-S10.
-
Hemostatic and Thrombotic Considerations in the Diagnosis and Management of Childhood Arterial Ischemic Stroke: A Narrative Review. Semin Pediatr Neurol. 2022 10; 43:101003.
-
Whole-exome sequencing of 14?389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Hum Mol Genet. 2022 09 10; 31(18):3120-3132.
-
Correlation between Thrombin Generation, Standard Coagulation Assays, and Viscoelastic Assays for Hemostatic Assessment in Critically Ill Children. J Appl Lab Med. 2022 09 01; 7(5):1108-1119.
-
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. Ann Thorac Surg. 2022 03; 113(3):1026-1035.
-
Transradial versus transfemoral access: The dispute continues. Catheter Cardiovasc Interv. 2020 08; 96(2):296-297.